WuXi AppTec Co., Ltd. (SHSE: 603259)
Health Care · Life Sciences Tools & Services · CN
CN¥161.00
+3.31% today · +61.0% 1Y
WuXi AppTec Co., Ltd. (SHSE: 603259) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $71.35B and employs 35,584 people.
Over the last twelve months the share price has gained 61.0%, trading between 87.09 and 173.60.
Tweenvest scores WuXi AppTec Co., Ltd. across four factors: quality 84/100, value 33/100, growth 85/100, dividend 71/100. Its strongest factor is growth.
603259 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $71.35B
- Revenue (TTM)
- $7.58B
- P/E
- 23.39
- EPS
- 7.37
- Dividend yield
- 1.24%
- Beta (5Y)
- 0.46
- 52-week high
- CN¥173.60
- 52-week low
- CN¥87.09
- Avg volume (3M)
- —
- Shares outstanding
- 2.94B
- Employees
- 35,584
- Next earnings
- —
About WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.
- ISIN
- CNE1000031K4
- Founded
- 2000
- Listed since
- May 8, 2018
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $625.73 | -0.39% |
| Danaher CorporationNYSE: DHR | $151.82B | $212.94 | -1.40% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF592.80 | -0.17% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $153.73 | -0.67% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $260.83 | +0.54% |
| Waters CorporationNYSE: WAT | $40.72B | $411.89 | -0.62% |
| Illumina, Inc.NasdaqGS: ILMN | $33.97B | $220.32 | -2.08% |
Figures last refreshed Aug 18, 2026.